# Cardiff International signs LOI to acquire MedicaMetrix

Cardiff International, Inc. signed a Letter of Intent to acquire MedicaMetrix, Inc. in an all-stock transaction valued at approximately $6 million. MedicaMetrix is the creator of the ProstaMetric medical device for prostate cancer diagnosis.

- Type: Acquisition
- Announced: 2017-05-09
- Where: United States
- Value: $6.00M
- Status: announced
- Products: ProstaMetric prostate cancer diagnostic device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cardiff International](https://endata.com/companies/24127.md) (acquirer)
- [MedicaMetrix](https://endata.com/companies/24128.md) (target)

## Sources

- [meddeviceonline.com](https://www.meddeviceonline.com/doc/cardiff-international-signs-loi-to-acquire-medicametrix-inc-0001), 2017-05-09: "We are pleased to welcome MedicaMetrix to the Cardiff family."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.